Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Medicenna Therapeutics Corp (MDNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C8288)・商品コード:DATA904C8288
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. Medicenna also offers clinical trial services. The company develops cytokines to deliver cell killing payloads to the bulk tumor, tumor microenvironment (TME), and cancer stem cells (CSC). It offers products in therapeutic areas including CNS cancers in glioblastoma multiforme, brain metastasis, padiatric gliloma, blood cancers, solid tumors, and bladder cancers. The company has operations in Canada and the US. Medicenna is headquartered in Toronto, Ontario, Canada.

Medicenna Therapeutics Corp (MDNA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medicenna Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 10
Licensing Agreements 11
Medicenna Therapeutics Enters into Licensing Agreement with Stanford University 11
Equity Offering 12
Medicenna Therapeutics Raises USD3 Million in Private Placement of Shares 12
Acquisition 13
A2 Acquisition Acquires Medicenna Therapeutics 13
Medicenna Therapeutics Corp – Key Competitors 14
Medicenna Therapeutics Corp – Key Employees 15
Medicenna Therapeutics Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 13, 2018: Medicenna announces first quarter fiscal 2019 financial results 17
Jun 27, 2018: Medicenna Reports March 31, 2018 Year-End Results 19
Feb 12, 2018: Medicenna Reports Third Quarter Fiscal 2018 Financial Results 21
Nov 13, 2017: Medicenna Reports Second Quarter Fiscal 2018 Financial Results 23
Aug 09, 2017: Medicenna Reports First Quarter Fiscal 2018 Financial Results 25
Jun 16, 2017: Medicenna Announces March 31, 2017 Year End Results 26
Corporate Communications 28
Oct 18, 2017: Medicenna Announces Trading on the OTCQX Best Market in the United States 28
Sep 21, 2017: Medicenna Appoints Dr. William Li to Board of Directors 29
Jul 17, 2017: Medicenna Bolsters Management Team 30
May 25, 2017: Medicenna Therapeutics Opens the Market 31
Mar 08, 2017: Medicenna shares resume trading under the symbol “MDNA” 32
Jan 18, 2017: Medicenna Further Strengthens Management Team 33
Jan 17, 2017: Medicenna Announces Additions to the Board of Directors 34
Clinical Trials 35
Jun 08, 2017: Medicennas Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology 35
Apr 20, 2017: Medicenna to Present at Bloom Burton & Co. Healthcare Investor Conference 2017 36
Apr 13, 2017: Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicenna Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Medicenna Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 10
Medicenna Therapeutics Enters into Licensing Agreement with Stanford University 11
Medicenna Therapeutics Raises USD3 Million in Private Placement of Shares 12
A2 Acquisition Acquires Medicenna Therapeutics 13
Medicenna Therapeutics Corp, Key Competitors 14
Medicenna Therapeutics Corp, Key Employees 15
Medicenna Therapeutics Corp, Subsidiaries 16

List of Figures
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicenna Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C8288)販売に関する免責事項を必ずご確認ください。
★調査レポート[Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆